The seed round was led by SFC Capital and will fund the continued development of the company technology.
"Novai’s innovative combination of technology and biomedicine represents the future of preventative care, with the potential to make a massive difference for anyone who might suffer from degenerative diseases in the future. The founders have assembled an extraordinary team of experts and advisors, and we are pleased to be supporting them as they continue to prove the capabilities of the technology and grow the company. We’re excited to see what they achieve next."
The funding round was backed by FNZ alongside industry executives and existing investors to expand enterprise capabilities.
"FNZ remains committed to solving the problems faced by consumers of long-term savings products, by using our own technological and servicing capabilities and by supporting wider independent innovations in the sector. We are building an ‘App Store’ for our platform customers, enabling startups and third-party providers to seamlessly connect with platforms and provide services to platform users – promoting choice within the wealth management solutions market."
Evolution Equity Partners led the Series C financing alongside participation from British Patient Capital, ABN AMRO Ventures, Dawn Capital, AlbionVC, HSBC and Accenture Ventures.
"We are thrilled that Evolution Equity Partners and British Patient Capital will be joining our team, alongside the strategic investment from ABN AMRO Ventures. Together with the continued trust and commitment from our existing investors, we will drive the next phase of Quantexa’s growth. We are seeing a huge demand for our platform to support multiple applications across our core markets in financial services and within new industry sectors. This investment will accelerate our product innovation roadmap and enable us to invest further into Europe, North America and Asia Pacific regions, as well as expand into new locations."
Catapult Ventures has backed the Manchester based digital health start-up to fund product trials.
"Healthbox CIC, is really excited to work alongside MyHelp. This new innovative product has huge potential not only to save money to an already overstretched mental health system but will also support people and, as an added bonus, save counsellors’ time."